Literature DB >> 16145218

Hyperkalemia: a review.

Kimberley J Evans1, Arthur Greenberg.   

Abstract

Potassium is the principal intracellular cation, and maintenance of the distribution of potassium between the intracellular and the extracellular compartments relies on several homeostatic mechanisms. When these mechanisms are perturbed, hypokalemia or hyperkalemia may occur. This review covers hyperkalemia, that is, a serum potassium concentration exceeding 5 mmol/L. The review includes a discussion of potassium homeostasis and the etiologies of hyperkalemia and focuses on the prompt recognition and treatment of hyperkalemia. This disorder should be of major concern to clinicians because of its propensity to cause fatal arrhythmias. Hyperkalemia is easily diagnosed, and rapid and effective treatments are readily available. Unfortunately, treatment of this life-threatening condition is often delayed or insufficiently attentive or aggressive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145218     DOI: 10.1177/0885066605278969

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  29 in total

1.  Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals.

Authors:  Elena Ramírez; Tomás Rossignoli; Armando J Campos; Raúl Muñoz; Claudia Zegarra; Hoi Tong; Nicolás Medrano; Alberto M Borobia; Antonio J Carcas; Jesús Frías
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

2.  Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.

Authors:  Jörg Indermitte; Sabine Burkolter; Jürgen Drewe; Stephan Krähenbühl; Kurt E Hersberger
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Case files of the medical toxicology fellowship of the California poison control system-San Francisco: calcium plus digoxin-more taboo than toxic?

Authors:  Christian P Erickson; Kent R Olson
Journal:  J Med Toxicol       Date:  2008-03

4.  Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ranee Chatterjee; Hsin-Chieh Yeh; Tariq Shafi; Cheryl Anderson; James S Pankow; Edgar R Miller; David Levine; Elizabeth Selvin; Frederick L Brancati
Journal:  Am J Clin Nutr       Date:  2011-03-02       Impact factor: 7.045

Review 5.  Drug-induced hyperkalemia.

Authors:  Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

Review 6.  [Water and electrolyte disturbances in critical care].

Authors:  T Matthäus; R Schnitzler; P Weithofer; M Weber; F Merkel
Journal:  Internist (Berl)       Date:  2006-11       Impact factor: 0.743

7.  A case of probable labetalol induced hyperkalaemia in pre-eclampsia.

Authors:  Binny Thomas; P V Abdul Rouf; Wessam El Kassem; Moza Al Hail; Derek Stewart; Asma Tharannum; Afif Ahmed; Muna Al Saadi
Journal:  Int J Clin Pharm       Date:  2014-11-05

8.  Potassium and risk of Type 2 diabetes.

Authors:  Ranee Chatterjee; Hsin-Chieh Yeh; David Edelman; Frederick Brancati
Journal:  Expert Rev Endocrinol Metab       Date:  2011-09

9.  Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.

Authors:  Laurence Lepage; Anne-Claude Dufour; Jessica Doiron; Katia Handfield; Katherine Desforges; Robert Bell; Michel Vallée; Michel Savoie; Sylvie Perreault; Louis-Philippe Laurin; Vincent Pichette; Jean-Philippe Lafrance
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-17       Impact factor: 8.237

10.  Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia.

Authors:  Josh Batterink; Jane Lin; Sarah Hin Mui Au-Yeung; Tara Cessford
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.